Literature DB >> 14652302

Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study.

Emily B Schroeder1, Verna Lamar Welch, David Couper, F Javier Nieto, Duanping Liao, Wayne D Rosamond, Gerardo Heiss.   

Abstract

The authors examined the association between lung function, as measured by forced expiratory volume in 1 second (FEV1) and forced vital capacity, and the 10-year incidence of coronary heart disease among 14,480 participants in the Atherosclerosis Risk in Communities Study (1987-1998). Separate proportional hazards models were used for FEV1 and forced vital capacity, with gender-specific lung function quartiles and lung function x gender interaction terms. An association between lung function and coronary heart disease was observed in both genders and was stronger among women. After adjustment for age, race, study center, height, height squared, smoking, and cardiovascular disease risk factors, the hazard ratios for the first (lowest), second, and third quartiles of FEV1 were 3.70 (95% confidence interval (CI): 2.19, 6.24), 2.54 (95% CI: 1.49, 4.32), and 2.25 (95% CI: 1.31, 3.87) for women and 1.51 (95% CI: 1.07, 2.13), 1.59 (95% CI: 1.15, 2.20), and 1.52 (95% CI: 1.10, 2.09) for men. After stratification by smoking status, associations were observed in each smoking group for women, while those in men were weaker and less consistent. Similar results were obtained for forced vital capacity. This analysis indicates an association between lung function and incident coronary heart disease that may be stronger in women than in men.

Entities:  

Mesh:

Year:  2003        PMID: 14652302     DOI: 10.1093/aje/kwg276

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  66 in total

1.  GOLD stage I is not a COPD risk factor.

Authors:  Paul L Enright
Journal:  Thorax       Date:  2007-12       Impact factor: 9.139

2.  Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study.

Authors:  Jennifer A Nettleton; Jack L Follis; Matthew B Schabath
Journal:  Am J Epidemiol       Date:  2009-04-16       Impact factor: 4.897

3.  Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study).

Authors:  Harjit Chahal; Susan R Heckbert; R Graham Barr; David A Bluemke; Aditya Jain; Mohammadali Habibi; Alvaro Alonso; Richard Kronmal; David R Jacobs; Joao A C Lima; Karol E Watson; Kiang Liu; Lewis J Smith; Philip Greenland
Journal:  Am J Cardiol       Date:  2015-03-24       Impact factor: 2.778

4.  Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes.

Authors:  Hwa Mu Lee; Yanglu Zhao; Michael A Liu; David Yanez; Mercedes Carnethon; R Graham Barr; Nathan D Wong
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

5.  ADAM19 and HTR4 variants and pulmonary function: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.

Authors:  Stephanie J London; Wei Gao; Sina A Gharib; Dana B Hancock; Jemma B Wilk; John S House; Richard A Gibbs; Donna M Muzny; Thomas Lumley; Nora Franceschini; Kari E North; Bruce M Psaty; Christie L Kovar; Josef Coresh; Yanhua Zhou; Susan R Heckbert; Jennifer A Brody; Alanna C Morrison; Josée Dupuis
Journal:  Circ Cardiovasc Genet       Date:  2014-06

6.  Lung function decline over 25 years of follow-up among black and white adults in the ARIC study cohort.

Authors:  Maria C Mirabelli; John S Preisser; Laura R Loehr; Sunil K Agarwal; R Graham Barr; David J Couper; John L Hankinson; Noorie Hyun; Aaron R Folsom; Stephanie J London
Journal:  Respir Med       Date:  2016-02-11       Impact factor: 3.415

7.  Sex-specific cardiopulmonary exercise testing parameters as predictors in patients with idiopathic pulmonary arterial hypertension.

Authors:  Ping Yuan; Hui-Juan Ni; Tian-Xiang Chen; Bigyan Pudasaini; Rong Jiang; Hui Liu; Qin-Hua Zhao; Lan Wang; Su-Gang Gong; Jin-Ming Liu
Journal:  Hypertens Res       Date:  2017-06-01       Impact factor: 3.872

8.  Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.

Authors:  Y Kubota; S J London; M Cushman; A M Chamberlain; W D Rosamond; S R Heckbert; N Zakai; A R Folsom
Journal:  J Thromb Haemost       Date:  2016-11-08       Impact factor: 5.824

9.  Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age.

Authors:  Erik J Giltay; Aulikki Nissinen; Simona Giampaoli; Daan Kromhout
Journal:  Dement Geriatr Cogn Disord       Date:  2009-11-10       Impact factor: 2.959

10.  Arterial inflammation in bronchial asthma.

Authors:  Jayanthi Vijayakumar; Sharath Subramanian; Parmanand Singh; Erin Corsini; Sara Fontanez; Meredith Lawler; Rebecca Kaplan; Thomas J Brady; Udo Hoffmann; Ahmed Tawakol
Journal:  J Nucl Cardiol       Date:  2013-03-23       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.